Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

R.Rodríguez-Lojo; M.Almagro; J. M.Barja; F.Pi?eyro; L.Pérez-Varela; J.Del Pozo; M. T.Yebra-Pimentel; E.Fonseca

首页> 外文期刊>Dermatology Research and Practice >Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

【24h】

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

机译：聚乙二醇干扰素α和利巴韦林治疗慢性丙型肝炎期间的皮下结节病

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well known. Recently, interferon-induced sarcoidosis has been reported. We report a new case of sarcoidosis during pegylated interferon alfa and ribavirin treatment with an unusual presentation in a woman with previous episodes of erythema nodusum and nodular vasculitis related to HCV.

机译：干扰素用于治疗丙型肝炎病毒感染，其皮肤副作用是众所周知的。最近，已经报道了干扰素引起的结节病。我们报道了在PEG化干扰素α和利巴韦林治疗期间结节病的新病例，该病例在与红斑结节和与HCV有关的结节性血管炎的先前发作的女性中表现异常。

著录项

来源
《Dermatology Research and Practice》 |2010年第1期|共3页
作者
R.Rodríguez-Lojo; M.Almagro; J. M.Barja; F.Pi?eyro; L.Pérez-Varela; J.Del Pozo; M. T.Yebra-Pimentel; E.Fonseca;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学;
关键词

相似文献

外文文献
中文文献
专利

1. Efficacy of pegylated interferon alfa-2a or alfa-2b in combination with ribavirin in the treatment of chronic hepatitis caused by hepatitis C virus genotype 1b [J] . Tomasz H. Mach, Andrzej Cie?la, Wioleta Warunek, Polish Archives of Internal Medicine . 2011,第12期

机译：聚乙二醇干扰素α-2a或α-2b联合利巴韦林治疗丙型肝炎病毒基因型1b引起的慢性肝炎的疗效
2. Efficacy and safety of pegylated interferon Alfa-2a or Alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: A systematic review and meta-analysis [J] . DruytsE., ThorlundK., WuP., Clinical infectious diseases . 2013,第7期

机译：聚乙二醇干扰素Alfa-2a或Alfa-2b联合利巴韦林治疗儿童和青少年慢性丙型肝炎的疗效和安全性：系统评价和荟萃分析
3. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. [J] . Antonini MG, Babudieri S, Maida I, Infection . 2008,第3期

机译：聚乙二醇化干扰素α-2a或α-2b加利巴韦林联合治疗慢性丙型肝炎期间中性粒细胞减少症和感染的发生率。
4. Studies of Therapy with Thymosin α 1 in Combination with Pegylated Interferon α2a and Ribavirin in Nonresponder Patients with Chronic Hepatitis C [C] . ROBERTO CAMERINI, ALESSIA CIANCIO, ALFONSO DE ROSA, International Symposiumn on Thymosins in Health and Disease; 20070321-24; Washington,DC(US) . 2007

机译：胸腺素α1联合聚乙二醇化干扰素α2a和利巴韦林治疗慢性丙型肝炎无反应者的研究
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C [O] . R. Rodríguez-Lojo, M. Almagro, J. M. Barja, 2010

机译：聚乙二醇干扰素α和利巴韦林治疗慢性丙型肝炎期间的皮下结节病
7. Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C [O] . Rodríguez-Lojo, R., Almagro, M., Barja, J. M., 2010

机译：聚乙二醇干扰素α和利巴韦林治疗慢性丙型肝炎期间的皮下结节病

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C

摘要

著录项

相似文献

相关主题

期刊订阅